Lluís Force
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS Research and Interventions 11
- HIV/AIDS drug development and treatment 11
- Epidemiology 12
- Hepatitis B Virus Studies 4
- Pneumonia and Respiratory Infections 3
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Co-authors
- Mateu Serra‐Prat (5 shared papers)Elísabet Palomera (5 shared papers)Père Clavé (1 shared paper)Jordi Almirall (1 shared paper)Montserrat Cabré i Pairet (1 shared paper)Peré Domingo (4 shared papers)Enric Pedrol (5 shared papers)Ferrán Segura (3 shared papers)
- Journals
- Antiviral Therapy (2 papers)AIDS Research and Human Retroviruses (2 papers)Clinical Infectious Diseases (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)HIV Medicine (1 paper)
- Partner nations
- SpainFranceUnited Kingdom
In The Last Decade
Lluís Force
26 papers receiving 900 citations
Peers
Comparison fields: 5 of 71
- Virology 322
- Infectious Diseases 533
- Emergency Medicine 232
- Speech and Hearing 149
- Hepatology 90
Countries citing papers authored by Lluís Force
This map shows the geographic impact of Lluís Force's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluís Force with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluís Force more than expected).
Fields of papers citing papers by Lluís Force
This network shows the impact of papers produced by Lluís Force. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluís Force. The network helps show where Lluís Force may publish in the future.
Co-authors
The 25 scholars most cited alongside Lluís Force, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 233 | |
| 2 | 2013 | 150 | |
| 3 | 1982 | 52 | |
| 4 | 2008 | 44 | |
| 5 | 2008 | 37 | |
| 6 | 2009 | 36 | |
| 7 | 2016 | 36 | |
| 8 | 2005 | 33 | |
| 9 | 2008 | 32 | |
| 10 | 2006 | 28 | |
| 11 | 2019 | 25 | |
| 12 | Early tocilizumab treatment could improve survival among COVID-19 patients. | 2020 | 24 |
| 13 | 2006 | 23 | |
| 14 | 2016 | 22 | |
| 15 | 2006 | 20 | |
| 16 | 2005 | 17 | |
| 17 | 2018 | 16 | |
| 18 | Short communication. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy. | 2005 | 15 |
| 19 | Osteonecrosis and HIV infection: 4 more cases. | 1998 | 14 |
| 20 | 2012 | 13 |
About Lluís Force
Lluís Force is a scholar working on Infectious Diseases, Epidemiology, Virology, Hepatology and Molecular Biology, having authored 28 papers that have together received 925 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers), Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers), Pneumonia and Respiratory Infections (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Sex work and related issues (2 papers). The work is most often cited by research in Virology (322 citations), Infectious Diseases (533 citations), Emergency Medicine (232 citations), Speech and Hearing (149 citations) and Hepatology (90 citations). Lluís Force has collaborated with scholars based in Spain, France and United Kingdom. Frequent co-authors include Mateu Serra‐Prat, Elísabet Palomera, Père Clavé, Jordi Almirall, Montserrat Cabré i Pairet, Peré Domingo, Enric Pedrol, Ferrán Segura, Bonaventura Clotet and Josep M. Llibre. Their work appears in journals such as Antiviral Therapy, AIDS Research and Human Retroviruses, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.